167 related articles for article (PubMed ID: 31346805)
1. The use of a proposed updated EARL harmonization of
Ly J; Minarik D; Edenbrandt L; Wollmer P; Trägårdh E
EJNMMI Res; 2019 Jul; 9(1):65. PubMed ID: 31346805
[TBL] [Abstract][Full Text] [Related]
2. Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
Enilorac B; Lasnon C; Nganoa C; Fruchart C; Gac AC; Damaj G; Aide N
J Nucl Med; 2018 Jul; 59(7):1049-1055. PubMed ID: 29242403
[TBL] [Abstract][Full Text] [Related]
3. The variation of quantitative parameters and Deauville scores with different reconstruction algorithms in FDG PET/CT imaging of lymphoma patients.
Genc M; Yildirim N; Coskun N; Ozdemir E; Turkolmez S
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):388-392. PubMed ID: 37524200
[TBL] [Abstract][Full Text] [Related]
4. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
[TBL] [Abstract][Full Text] [Related]
5. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
van Sluis J; van Snick JH; Brouwers AH; Noordzij W; Dierckx RAJO; Borra RJH; Slart RHJA; Lammertsma AA; Glaudemans AWJM; Boellaard R; Tsoumpas C
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4652-4660. PubMed ID: 35876867
[TBL] [Abstract][Full Text] [Related]
6. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
[TBL] [Abstract][Full Text] [Related]
7. How Often Do We Fail to Classify the Treatment Response with [
Mattoli MV; Calcagni ML; Taralli S; Indovina L; Spottiswoode BS; Giordano A
Mol Imaging Biol; 2019 Dec; 21(6):1210-1219. PubMed ID: 30850971
[TBL] [Abstract][Full Text] [Related]
8. Semi-automated
Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
[TBL] [Abstract][Full Text] [Related]
9. Assessment of alteration in liver
Salomon T; Nganoa C; Gac AC; Fruchart C; Damaj G; Aide N; Lasnon C
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):941-950. PubMed ID: 29279943
[TBL] [Abstract][Full Text] [Related]
10. Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for
Trägårdh E; Minarik D; Almquist H; Bitzén U; Garpered S; Hvittfelt E; Olsson B; Oddstig J
EJNMMI Res; 2019 Jul; 9(1):64. PubMed ID: 31342214
[TBL] [Abstract][Full Text] [Related]
11. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.
Aide N; Lasnon C; Veit-Haibach P; Sera T; Sattler B; Boellaard R
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):17-31. PubMed ID: 28623376
[TBL] [Abstract][Full Text] [Related]
12. Quantitative and clinical implications of the EARL2 versus EARL1 [
Cox MC; Jurcka T; Arens AIJ; van Rijk MC; Kaanders JHAM; van den Bosch S
EJNMMI Res; 2023 Oct; 13(1):91. PubMed ID: 37878160
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.
Kaalep A; Sera T; Oyen W; Krause BJ; Chiti A; Liu Y; Boellaard R
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):412-422. PubMed ID: 29192365
[TBL] [Abstract][Full Text] [Related]
15. SUV Harmonization Between Different Hybrid PET/CT Systems.
Rubello D; Colletti PM
Clin Nucl Med; 2018 Nov; 43(11):811-814. PubMed ID: 30199381
[TBL] [Abstract][Full Text] [Related]
16. Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
Biggi A; Bergesio F; Chauvie S; Bianchi A; Menga M; Fallanca F; Hutchings M; Gregianin M; Meignan M; Gallamini A
Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):410-415. PubMed ID: 28750493
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis imaging study using interim [
Tonnelet D; Bohn MDP; Becker S; Decazes P; Camus V; Thureau S; Tilly H; Jardin F; Vera P
EJNMMI Res; 2021 Apr; 11(1):37. PubMed ID: 33846870
[TBL] [Abstract][Full Text] [Related]
18. Revisiting detection of in-transit metastases in melanoma patients using digital
Zimmermann PA; Houdu B; Césaire L; Nakouri I; De Pontville M; Lasnon C; Aide N
Ann Nucl Med; 2021 Jun; 35(6):669-679. PubMed ID: 33770374
[TBL] [Abstract][Full Text] [Related]
19. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
[TBL] [Abstract][Full Text] [Related]
20. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Khong PL; Huang B; Lee EY; Chan WK; Kwong YL
J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
